期刊
FUTURE MEDICINAL CHEMISTRY
卷 5, 期 6, 页码 705-714出版社
FUTURE SCI LTD
DOI: 10.4155/FMC.13.47
关键词
-
资金
- Institute of Chemical and Engineering Sciences in Singapore
- National Science Foundation [CHE-0906179]
- NIU Inaugural Board of Trustees Professorship Award
- Chinese Academy of Sciences
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [0906179] Funding Source: National Science Foundation
Recently, boron compounds have attracted increasing attention both in academic laboratories and in the pharmaceutical industry. Boron, in particular the B-10 isotope, has the unique capability of absorbing a slow neutron to initiate a nuclear reaction with release of energetic particles such as alpha- and Li-particles, which is not observed in its carbon analogues. The nuclear capture reaction concept has been adopted in radiation therapy and used in boron neutron capture therapy (BNCT). BNCT is a potentially promising treatment for malignant brain tumors as well as other cancers, despite the limitation of a scarcity of neutron sources. There is the need in advanced research centers to construct high boron-containing composites as BNCT agents and develop more efficient drug carriers. This review discusses recent works on the development of boron-based therapeutic nanomaterials as BNCT agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据